← Leaderboards
Henry J Lin
La Biomed Res Inst/ Harbor Ucla Med Ctr
$1,961,438
Attributed
$1,961,438
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $258.6K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,961,438 · 6
By mechanism
R01$1,402,161 · 2
M01$292,237 · 2
R03$267,040 · 2
Top collaborators
No co-investigators on record.
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- Rowan T. Chlebowski$4,676,800
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectNeoplasm /Cancer GeneticsProstaglandin Endoperoxide SynthaseAdenomaLaboratory MouseGene MutationCancer PreventionPeroxisome Proliferator Activated ReceptorGene TargetingGenetically Modified AnimalsPhospholipase A2Neoplasm /Cancer EpidemiologyGenetic PolymorphismChemopreventionModel Design /DevelopmentDisease /Disorder ModelGastrointestinal Imaging /VisualizationHyperglycemiaCarcinogenesis InhibitorEndoscopyComorbidityColorectal NeoplasmsAfrican American
Grant awards (16)
Prostaglandin D and skin cancer prevention$65,651
R03 · FY2008 · CA · contact PI
Prostaglandin D and skin cancer prevention$65,651
R03 · FY2007 · CA · contact PI
GENES, ANTICARCINOGENS AND COLON NEOPLASMS$195,300
R01 · FY2006 · CA · contact PI
GENES, ANTICARCINOGENS AND COLON NEOPLASMS$258,589
R01 · FY2005 · CA
GENES, ANTICARINOGENS AND COLON NEOPLASMS$58,589
R01 · FY2004 · CA
Genes, Anti-Carcinogens, and Colon Neoplasms$53,277
M01 · FY2004 · RR
GENES, ANTICARINOGENS AND COLON NEOPLASMS$258,589
R01 · FY2003 · CA
GENES, ANTICARINOGENS AND COLON NEOPLASMS$258,589
R01 · FY2002 · CA
PROSTAGLANDINS AND COLON ADENOMAS$67,869
R03 · FY2002 · CA
GENES, ANTICARINOGENS AND COLON NEOPLASMS$258,589
R01 · FY2001 · CA
INTERDEPENDENCE OF HYPERGLYCEMIA &GASTRIC MOTILITY IN DIABETES$237,978
M01 · FY2001 · RR
PROSTAGLANDINS AND COLON ADENOMAS$67,869
R03 · FY2001 · CA
GENE-ENVIRONMENT EFFECTS AND COLON ADENOMAS$113,916
R01 · FY2000 · CA
INTERDEPENDENCE OF HYPERGLYCEMIA &GASTRIC MOTILITY IN DIABETES$982
M01 · FY2000 · RR
INTERDEPENDENCE OF HYPERGLYCEMIA &GASTRIC MOTILITY IN DIABETES$0
M01 · FY2000 · RR
INTERDEPENDENCE OF HYPERGLYCEMIA &GASTRIC MOTILITY IN DIABETES$0
M01 · FY2000 · RR